Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin [Phase 3]
Phase 3 trial comparing BID insulin degludec/insulin aspart versus once-daily insulin degludec with mealtime insulin aspart in type 2 diabet…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine [Phase 3]
A Phase 3 trial comparing two dose adjustment regimens for the insulin degludec/insulin aspart combination in people with type 2 diabetes pr…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Phase 2 Study of NGM282 in Patients With Type 2 Diabetes [Phase 2]
Phase 2 study of NGM282 in patients with Type 2 diabetes has completed.
-
CLINICAL_TRIALS research · 2015-11-17Clinical Trial Update: Purified Anthocyanins Supplementation in Type 2 Diabetes Mellitus [EARLY_Phase 1]
This entry reports the completion of an early-phase clinical trial assessing purified anthocyanin supplementation in individuals with type 2…
-
CLINICAL_TRIALS research · 2015-11-17Clinical Trial Update: A Clinical Trial Analyzing Effects of Prokinetic Drug on the Blood Glucose in Patients With Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial is examining the effects of a prokinetic drug on blood glucose in adults with Type 2 diabetes.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-11-17Clinical Trial Update: Effects of Various Bariatric Surgical Procedures on Intestinal TRL Metabolism in Obese Type 2 Diabetic Patients [NA]
This document is a clinical trial update examining how different bariatric surgical procedures influence intestinal triglyceride-rich lipopr…
-
CLINICAL_TRIALS trial_result · 2015-11-16Clinical Trial Update: Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes [Phase 2]
A Phase 2 study comparing two NN1250 insulin formulations against insulin glargine, both in combination with metformin, in adults with type …
-
CLINICAL_TRIALS research · 2015-11-16Clinical Trial Update: Acupuncture in the Complementary Treatment of Diabetes Mellitus Type II [NA]
This document summarizes a clinical trial update investigating acupuncture as a complementary treatment for Type 2 diabetes mellitus; sponso…
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes [Phase 3]
A Phase 3 trial compared NN1250 with insulin glargine in adults with Type 2 diabetes; the study has completed and results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing NN1250 with insulin glargine in adults with type 2 diabetes was completed, and results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing NN1250 to insulin glargine in adults with type 2 diabetes; results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing NN1250 with insulin glargine plus insulin aspart, with/without metformin and with/without pioglitazone, in people …
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 study comparing NN1250 to insulin glargine in adults with type 2 diabetes has completed and results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls [Phase 1]
Phase 1 clinical trial evaluating quantitative PET imaging with 18F-AV-133 to visualize VMAT2 in the pancreas of individuals with Type 2 dia…
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily [Phase 3]
Phase 3 trial comparing adding once-daily insulin aspart versus switching to a basal-bolus regimen with insulin degludec and insulin aspart …
-
CLINICAL_TRIALS trial_result · 2015-11-10Clinical Trial Update: Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing NN1250 with insulin glargine in adults with type 2 diabetes completed; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: Effect of Exercise Frequency on Metabolic Control and Heart Function in Type 2 Diabetes [NA]
A completed clinical study investigating how exercise frequency impacts metabolic control and heart function in individuals with Type 2 diab…
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: Multiple Ascending Dose Study in Subjects With Type 2 Diabetes [Phase 1]
A Phase 1 multiple ascending dose trial in subjects with Type 2 diabetes mellitus has been terminated.
-
FDA approval · 2015-11-05FDA Approved: PIOGLITAZONE AND METFORMIN HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approves Macleods Pharmaceuticals Limited's Pioglitazone and Metformin Hydrochloride as an original ANDA. The product is indicated for t…
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Pharmacogenetics of Ace Inhibitor-Associated Angioedema [NA]
Completed pharmacogenetics study examining genetic factors in ACE inhibitor–associated angioedema among people with hypertension and type 2 …
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Pharmaceutical Care Program for Type 2 Diabetes Mellitus [NA]
Completed clinical trial evaluating a Pharmaceutical Care Program for patients with Type 2 diabetes mellitus.
-
CLINICAL_TRIALS research · 2015-11-03Clinical Trial Update: Gingival Crevicular Fluid Vaspin and Omentin Levels in Type 2 Diabetic Patients With Chronic Periodontitis [NA]
The trial has completed and reports biomarker measurements (vaspin and omentin) in gingival crevicular fluid from patients with Type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015) [Phase 3]
A Phase 3 clinical trial update for Omarigliptin as add-on therapy to oral antihyperglycemic agents in Japanese patients with Type 2 Diabete…
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Omarigliptin (MK-3102) Clinical Trial - Placebo- and Sitagliptin-Controlled Monotherapy Study in Japanese Patients With Type 2 Diabetes Mellitus (MK-3102-020) [Phase 3]
Phase 3 trial update for omarigliptin (MK-3102) in Japanese patients with type 2 diabetes mellitus; completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: The Features Behind the Beneficial Effects of Interval-walking [NA]
A completed clinical trial investigates the beneficial effects of interval-walking in people with Type 2 diabetes.